References
Reference articles
1. Sayer JA, Carr G, Simmons NL. Nephrocalcinosis: molecular insights into calcium precipitation within the kidney. Clin Sci (Lond). 2004 Jun;106(6):549-61.Full text Abstract
2. Minisola S, Pepe J, Piemonte S, et al. The diagnosis and management of hypercalcaemia. BMJ. 2015 Jun 2;350:h2723.Full text Abstract
3. Sinton TJ, Cowley DM, Bryant SJ. Reference intervals for calcium, phosphate, and alkaline phosphatase as derived on the basis of multichannel-analyzer profiles. Clin Chem. 1986 Jan;32(1 pt 1):76-9. Abstract
4. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr. 1999;69:842-56. Abstract
5. Moe SM. Calcium homeostasis in health and in kidney disease. Compr Physiol. 2016 Sep 15;6(4):1781-800.Full text Abstract
6. Ross AC, Taylor CL, Yaktine AL, et al, eds. Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium: Dietary reference intakes for calcium and vitamin D. Washington (DC): National Academies Press (US); 2011.Full text Abstract
7. Wolf RL, Cauley JA, Baker CE, et al. Factors associated with calcium absorption efficiency in pre- and perimenopausal women. Am J Clin Nutr. 2000 Aug;72(2):466-71.Full text Abstract
8. Bilezikian JP, Brandi ML, Eastell R, et al. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab. 2014 Oct;99(10):3561-9.Full text Abstract
9. National Institute for Health and Care Excellence. Hyperparathyroidism (primary): diagnosis, assessment and initial management. May 2019 [internet publication].Full text
10. Walsh J, Gittoes N, Selby P, the Society for Endocrinology Clinical Committee. Society for Endocrinology Endocrine emergency guidance: Emergency management of acute hypercalcaemia in adult patients. Endocrine Connect. 2016;5:G9–11. Abstract
11. Jacobs TP, Bilezikian JP. Clinical review: rare causes of hypercalcemia. J Clin Endocrinol Metab. 2005;90:6316-22.Full text Abstract
12. Press DM, Siperstein AE, Berber E, et al. The prevalence of undiagnosed and unrecognized primary hyperparathyroidism: a population-based analysis from the electronic medical record. Surgery. 2013 Dec;154(6):1232-7; discussion 1237-8.Full text Abstract
13. Walker MD, Silverberg SJ. Primary hyperparathyroidism. Nat Rev Endocrinol. 2018 Feb;14(2):115-25.Full text Abstract
14. Wysolmerski JJ. Parathyroid hormone-related protein: an update. J Clin Endocrinol Metab. 2012 Sep;97(9):2947-56.Full text Abstract
15. Goldner W. Cancer-Related Hypercalcemia. J Oncol Pract. 2016 May;12(5):426-32.Full text Abstract
17. Grieff M, Bushinsky DA. Diuretics and disorders of calcium homeostasis. Semin Nephrol. 2011 Nov;31(6):535-41.Full text Abstract
18. Vakiti A, Mewawalla P. Malignancy-related hypercalcemia. StatPearls Publishing, Treasure Island, Florida, USA; 2021.Full text
19. Turner JJO. Hypercalcaemia-presentation and management. Clin Med (Lond). 2017 Jun;17(3):270-73.Full text Abstract
20. Eremkina A, Krupinova J, Dobreva E, et al. Denosumab for management of severe hypercalcemia in primary hyperparathyroidism. Endocr Connect. 2020 Oct;9(10):1019-1027.Full text Abstract
21. Reynolds BC, Cheetham TD. Bones, stones, moans and groans: hypercalcaemia revisited. Arch Dis Child Educ Pract Ed. 2015 Feb;100(1):44-51.Full text Abstract
22. Mirrakhimov AE. Hypercalcemia of malignancy: An update on pathogenesis and management. N Am J Med Sci. 2015;7(11):483–93.Full text Abstract
23. Murray DL, Puig N, Kristinsson S, et al. Mass spectrometry for the evaluation of monoclonal proteins in multiple myeloma and related disorders: an International Myeloma Working Group Mass Spectrometry Committee Report. Blood Cancer J. 2021 Feb 1;11(2):24.Full text Abstract
24. Marx SJ. Familial hypocalciuric hypercalcemia as an atypical form of primary hyperparathyroidism. J Bone Miner Res. 2018 Jan;33(1):27-31.Full text Abstract
Use of this content is subject to our disclaimer